Abstract
The tumor suppressor PTEN is a lipid phosphatase that is found mutated in different types of human cancers. PTEN suppresses cell proliferation by inhibiting the PI3K-Akt signaling pathway at the cell membrane. However, PTEN is also demonstrated to localize in the cell nucleus where it exhibits tumor suppressive activity via a different, unknown mechanism. In this study we report that PTEN also localizes to the nucleolus and that nucleolar PTEN plays an important role in regulating nucleolar homeostasis and maintaining nucleolar morphology. Overexpression of nuclear PTEN in PTEN null cells inhibits Akt phosphorylation and reduces cell size. Knockdown of PTEN in PTEN positive cells leads to nucleolar morphologic changes and an increase in the proportion of cells with a greater number of nucleoli. In addition, knockdown of PTEN in PTEN positive cells increased ribosome biogenesis. These findings expand current understanding of function and relevance of nuclear localized PTEN and provide a foundation for the development of novel therapies targeting PTEN.
Similar content being viewed by others
References
Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI (2007) The multifunctional nucleolus. Nat Rev Mol Cell Biol 8:574–585
Coute Y, Burgess JA, Diaz JJ, Chichester C, Lisacek F et al (2006) Deciphering the human nucleolar proteome. Mass Spectrom Rev 25:215–234
Scherl A, Coute Y, Deon C, Calle A, Kindbeiter K et al (2002) Functional proteomic analysis of human nucleolus. Mol Biol Cell 13:4100–4109
Derenzini M, Ploton D (1991) Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol 32:149–192
David-Pfeuty T (2006) The flexible evolutionary anchorage-dependent Pardee’s restriction point of mammalian cells: how its deregulation may lead to cancer. Biochim Biophys Acta 1765:38–66
Ruggero D, Pandolfi PP (2003) Does the ribosome translate cancer? Nat Rev Cancer 3:179–192
Sulic S, Panic L, Dikic I, Volarevic S (2005) Deregulation of cell growth and malignant transformation. Croat Med J 46:622–638
Montanaro L, Trere D, Derenzini M (2008) Nucleolus, ribosomes, and cancer. Am J Pathol 173:301–310
Maehama T, Taylor GS, Dixon JE (2001) PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem 70:247–279
Sansal I, Sellers WR (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22:2954–2963
Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C et al (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29–39
Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M et al (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997–5000
Feilotter HE, Nagai MA, Boag AH, Eng C, Mulligan LM (1998) Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Oncogene 16:1743–1748
Gray IC, Stewart LM, Phillips SM, Hamilton JA, Gray NE et al (1998) Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Br J Cancer 78:1296–1300
Li DM, Sun H (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57:2124–2129
Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H et al (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362
Ali IU, Schriml LM, Dean M (1999) Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 91:1922–1932
Salmena L, Carracedo A, Pandolfi PP (2008) Tenets of PTEN tumor suppression. Cell 133:403–414
Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP (1998) Pten is essential for embryonic development and tumour suppression. Nat Genet 19:348–355
Eng C (2003) PTEN: one gene, many syndromes. Hum Mutat 22:183–198
Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J et al (2007) Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128:141–156
Shen WH, Balajee AS, Wang J, Wu H, Eng C et al (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128:157–170
Blanco-Aparicio C, Renner O, Leal JF, Carnero A (2007) PTEN, more than the AKT pathway. Carcinogenesis 28:1379–1386
Georgescu MM, Kirsch KH, Kaloudis P, Yang H, Pavletich NP et al (2000) Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res 60:7033–7038
Gildea JJ, Herlevsen M, Harding MA, Gulding KM, Moskaluk CA et al (2004) PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene 23:6788–6797
Koul D, Jasser SA, Lu Y, Davies MA, Shen R et al (2002) Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene 21:2357–2364
Maier D, Jones G, Li X, Schonthal AH, Gratzl O et al (1999) The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res 59:5479–5482
A EM (2007) Isolation and propagation of mouse embryonic fibroblasts and preparation of mouse embryonic feeder layer cells. Curr Protoc Stem Cell Biol Chapter 1:Unit1C 3
Busch H, Muramatsu M, Adams H, Steele WJ, Liau MC et al (1963) Isolation of Nucleoli. Exp Cell Res 24(SUPPL9):150–163
Belin S, Beghin A, Solano-Gonzalez E, Bezin L, Brunet-Manquat S et al (2009) Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PLoS ONE 4:e7147
Gimm O, Perren A, Weng LP, Marsh DJ, Yeh JJ et al (2000) Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol 156:1693–1700
Perren A, Weng LP, Boag AH, Ziebold U, Thakore K et al (1999) Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 155:1253–1260
Sano T, Lin H, Chen X, Langford LA, Koul D et al (1999) Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 59:1820–1824
Perren A, Komminoth P, Saremaslani P, Matter C, Feurer S et al (2000) Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol 157:1097–1103
Whiteman DC, Zhou XP, Cummings MC, Pavey S, Hayward NK et al (2002) Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. Int J Cancer 99:63–67
Gillooly DJ, Morrow IC, Lindsay M, Gould R, Bryant NJ et al (2000) Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J 19:4577–4588
Irvine RF (2003) Nuclear lipid signalling. Nat Rev Mol Cell Biol 4:349–360
Martelli AM, Tabellini G, Borgatti P, Bortul R, Capitani S et al (2003) Nuclear lipids: new functions for old molecules? J Cell Biochem 88:455–461
Acknowledgments
This research was supported by the following grants: Research Fund for the Doctoral Program of Higher Education (20101107110005), Beijing Natural Science Foundation (7122039).
Author information
Authors and Affiliations
Corresponding author
Additional information
Pingdong Li and Danni Wang authors are contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, P., Wang, D., Li, H. et al. Identification of nucleolus-localized PTEN and its function in regulating ribosome biogenesis. Mol Biol Rep 41, 6383–6390 (2014). https://doi.org/10.1007/s11033-014-3518-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-014-3518-6